Valuation : BELE LIFEPAR

Market Cap 46.6M 40M 37.45M 34.29M 64.59M 4.45B 64.78M 443M 173M 2.24B 175M 171M 7.42B P/E 2022 *
-
P/E 2023 210x
Enterprise Value 46.65M 40.05M 37.49M 34.33M 64.67M 4.46B 64.86M 444M 174M 2.25B 175M 171M 7.43B EV / Sales 2022 *
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -
1 day+1.49%
Current month-94.35%
Current year-94.35%
3 years 0.14
Extreme 0.136
13.4
5 years 0.14
Extreme 0.136
13.4
10 years 0.14
Extreme 0.136
13.4

Financials

2022 2023
Net sales - -
Net income -35.39K -30.38K -28.44K -26.04K -49.06K -3.38M -49.2K -337K -132K -1.7M -133K -130K -5.64M 404K 347K 324K 297K 560K 38.56M 561K 3.84M 1.5M 19.44M 1.52M 1.48M 64.33M
Net Debt 1.09M 938K 878K 804K 1.51M 104M 1.52M 10.4M 4.06M 52.59M 4.1M 4.01M 174M 56.58K 48.57K 45.47K 41.64K 78.44K 5.4M 78.66K 538K 210K 2.72M 212K 208K 9.01M
Logo BELE LIFEPAR
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.
Employees
-
Sector
-
Date Price Change
26-08-27 US$0.1700 +1.49%
26-08-26 US$0.1675 +43.78%
26-08-25 US$0.1165 -53.40%
26-08-24 US$0.2500 -9.75%
26-08-21 US$0.2770 -6.07%
  1. Stock Market
  2. Stocks
  3. BLAC Stock